我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

主动固定电极3830与传统主动电极的比较研究(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第2期
页码:
176-179
栏目:
临床研究
出版日期:
2016-11-25

文章信息/Info

Title:
Comparative study of 3830 active-fixation lead and traditional active-fixation lead
作者:
赵 辉; 王 波; 王莹惠; 李述峰; 栾 颖
（哈尔滨医科大学附属第二医院心内科，黑龙江 哈尔滨 150086）
Author(s):
ZHAO Hui;  WANG Bo;  WANG Ying-hui;  LI Shu-feng;  LUAN Ying
(Department of Cardiology, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, Heilongjiang, China)
关键词:
心脏起搏; 主动固定电极; 阈值; 阻抗; 并发症
Keywords:
cardiac pacing;  active fixation lead;  threshold;  impedance;  complications
分类号:
R541.72
DOI:
-
文献标识码:
A
摘要:
目的 观察3830主动固定电极在临床心脏起搏治疗的可行性和安全性。方法 选择2008年~2012年在我院植入永久性人工双腔心脏起搏器的患者225例，包括3830主动固定电极组134例和5076主动固定电极组91例。观察两组术中及术后1周、1个月、3个月、1年和3年的起搏参数和相关并发症的发生情况。结果 心房起搏参数比较，3830主动固定电极组起搏阈值和阻抗在术中及术后不同时间均高于5076主动固定电极组（P<0.05，P<0.01），感知参数无明显差异。心室电极术中及术后不同时间的起搏参数比较，感知参数差异无统计学意义，阻抗差异有统计学意义（P<0.05，P<0.01），起搏阈值在术中及术后1周差异有统计学意义（P<0.05，P<0.01）。3830组心房电极在心房不同部位的起搏参数比较，差异均无统计学意义。两组术后3年内出现相关并发症的比较，差异无统计学意义。结论 3830主动固定电极在临床心脏起搏治疗中安全可行。
Abstract:
AIM To investigate the feasibility and safety of 3830 active fixation leads in clinical cardiac pacing. METHODS Selected for this study were 225 patients with permanent artificial double-chamber pacemaker implantation in our hospital between 2008 and 2012, including 134 patients with 3830 active fixation leads and 91 patients with 5076 active fixation leads. The pacing parameters and the related complications of the two groups were recorded during and after the procedure and compared accordingly. RESULTS The atrial threshold and impedance in the 3830 lead group were significantly higher than in the 5076 lead group (P<0.05, P<0.01) during and after the procedure. No significant difference was found in atrial perception and ventricular perception between groups. The ventricular threshold was significantly different between groups during and 1 week after the procedure (P<0.05, P<0.01). There was no significant difference in the pacing parameters between different parts of the atrium in the 3830 lead group and there was no significant difference in the complications between groups. CONCLUSION The application of 3830 active fixation leads is feasible and safe in clinical cardiac pacing.

参考文献/References

[1]Molina L,Sutton R,Gandoy W,et al.Medium-term effects of septal and apical pacing in pacemaker-dependent patients a double-blind prospective randomized study[J].Pacing Clin Electrophysiol,2014,37(2):207-214.
[2]Lau CP,Tachapong N,Wang CC,et al.Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome:Septal Pacing for Atrial Fibrillation Suppression Evaluation(SAFE)Study[J].Circulation,2013,128(7):687-693.
[3]Fishberger SB,Rollinson NR,Warsy I,et al.Transatrial lead implantation using the 4-Fr lumenless pacing lead and delivery system in young adults with congenital heart disease[J].Pacing Clin Electrophysiol,2009,32(12):e40-e42.
[4]Khan A,Zelin K,Karpawich PP.Performance of the lumenless 4.1-Fr diameter pacing lead implanted at alternative pacing sites in congenital heart:a chronic 5-year comparison[J].Pacing Clin Electrophysiol,2010,33(12):1467-1474.

备注/Memo

备注/Memo:
收稿日期：2016-01-20.
基金项目：国家自然科学基金青年项目资助(81200130)
通讯作者：栾颖，主任医师，主要从事心律失常的基础及临床研究 Email：drluanying@163.com
作者简介：赵辉，硕士生 Email：994947309@qq.com
更新日期/Last Update: 2016-10-11